RxDoctor Payments Data

Ravi Kankotia, MD

Internal Medicine · Ann Arbor, MINPI 1275996613

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.3%), education and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Olympus Corporation Of The Americas at 32.1% of the total. 2025 is the largest year on record at $3,920, more than ten times the $12 reported in 2021. Among internal medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,508in general payments, 2019–2025

Across 54 payments — averaging $120.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation Of The Americas$2K
  • Boston Scientific$2K
  • Medtronic$767
  • Conmed Corporation$601
  • Cook Medical LLC$555
  • Fujifilm Healthcare Americas Corporation$366
  • plus $493 from 6 others
$6,500in research payments, 2019–2025

Across 1 payment — averaging $6500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gyrus ACMI, Inc.$7K

What the payments were for

  • Travel & lodging$1,26719%
  • Food & beverage$3,01646%
  • Education$2,22534%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,508 in reported general payments places this provider in the 90th percentile of 4,567 internal medicine providers in Michigan.

See all internal medicine providers in Michigan →

Medicare billing

Part B allowed, 2024
$155,607
Medicare patients
292
Services billed
929

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole11$99
Levofloxacin20$41

Paid to pharmacies, not to this prescriber.

Other internal medicine in Ann Arbor

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →